Double-Blind, Placebo-Controlled Study of Lurasidone Monotherapy for the Treatment of Bipolar I Depression

MLA

Mari Miyajima, et al. Double-Blind, Placebo-Controlled Study of Lurasidone Monotherapy for the Treatment of Bipolar I Depression. Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0473aa61612b3c7c09217cf9bf92c8a6&authtype=sso&custid=ns315887.

APA

Mari Miyajima, Kei Watabe, Jun Ishigooka, Teruhiko Higuchi, Tadafumi Kato, Eduard Vieta, Takahiro Masuda, & Tomohiro Fujimori. (2020). Double-Blind, Placebo-Controlled Study of Lurasidone Monotherapy for the Treatment of Bipolar I Depression.

Chicago

Mari Miyajima, Kei Watabe, Jun Ishigooka, Teruhiko Higuchi, Tadafumi Kato, Eduard Vieta, Takahiro Masuda, and Tomohiro Fujimori. 2020. “Double-Blind, Placebo-Controlled Study of Lurasidone Monotherapy for the Treatment of Bipolar I Depression,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0473aa61612b3c7c09217cf9bf92c8a6&authtype=sso&custid=ns315887.